Neuropsychiatric Disturbances in Dystonia

[1]  N. Brüggemann,et al.  Non-motor phenotype of dopa-responsive dystonia and quality of life assessment. , 2014, Parkinsonism & related disorders.

[2]  M. Stacy,et al.  Cognitive impairment in rapid‐onset dystonia‐parkinsonism , 2014, Movement disorders : official journal of the Movement Disorder Society.

[3]  D. Martino,et al.  Impaired cognitive functions in adult-onset primary cranial cervical dystonia. , 2014, Parkinsonism & related disorders.

[4]  R. Boyle,et al.  Psychiatric disorders in idiopathic-isolated focal dystonia , 2014, Journal of Neurology.

[5]  Margot J. Taylor,et al.  The centre of the brain: Topographical model of motor, cognitive, affective, and somatosensory functions of the basal ganglia , 2013, Human brain mapping.

[6]  T. Robbins,et al.  Inhibition and impulsivity: Behavioral and neural basis of response control , 2013, Progress in Neurobiology.

[7]  M. Hornberger,et al.  Beyond and below the cortex: the contribution of striatal dysfunction to cognition and behaviour in neurodegeneration , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  K. Bhatia,et al.  The genetics of dystonia: new twists in an old tale , 2013, Brain : a journal of neurology.

[9]  William W. McDonald,et al.  Psychiatric comorbidities in dystonia: Emerging concepts , 2013, Movement disorders : official journal of the Movement Disorder Society.

[10]  M. Hallett,et al.  Phenomenology and classification of dystonia: A consensus update , 2013, Movement disorders : official journal of the Movement Disorder Society.

[11]  N. Diaz.  Late Onset Atypical Pantothenate-Kinase-Associated Neurodegeneration , 2013, Case reports in neurological medicine.

[12]  Y. Jiang,et al.  Follow‐up study of 25 Chinese children with PLA2G6‐associated neurodegeneration , 2013, European journal of neurology.

[13]  N. Brüggemann,et al.  Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. , 2012, Archives of neurology.

[14]  S. Schneider,et al.  Neurodegeneration with brain iron accumulation. , 2012, Current opinion in neurology.

[15]  M. Stacy,et al.  New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism. , 2012, Parkinsonism & related disorders.

[16]  M. Hallett,et al.  The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. , 2012, Brain : a journal of neurology.

[17]  M. Contarino,et al.  Cognition and psychopathology in myoclonus-dystonia , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  S. Rauch,et al.  Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways , 2012, Trends in Cognitive Sciences.

[19]  J. Hardy,et al.  Syndromes of neurodegeneration with brain iron accumulation (NBIA): An update on clinical presentations, histological and genetic underpinnings, and treatment considerations , 2012, Movement disorders : official journal of the Movement Disorder Society.

[20]  A. Albanese,et al.  Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis , 2011, The Lancet Neurology.

[21]  P. Bugalho,et al.  Obsessive‐compulsive symptoms in primary focal dystonia: A controlled study , 2011, Movement disorders : official journal of the Movement Disorder Society.

[22]  Leonardo Franklin Fontenelle,et al.  Obsessive-compulsive symptoms among patients with blepharospasm and hemifacial spasm. , 2011, General hospital psychiatry.

[23]  M. Owen,et al.  Psychiatric disorders, myoclonus dystonia, and the epsilon‐sarcoglycan gene: A systematic review , 2011, Movement disorders : official journal of the Movement Disorder Society.

[24]  G. Peters,et al.  Familial 7q21.3 microdeletion involving epsilon‐sarcoglycan causing myoclonus dystonia, cognitive impairment, and psychosis , 2011, Movement disorders : official journal of the Movement Disorder Society.

[25]  D. Duane,et al.  Additional clinical observations on psychiatric disorders in adult‐onset focal dystonia: A case control study , 2011, Movement disorders : official journal of the Movement Disorder Society.

[26]  E. Scarnati,et al.  Where are the somatosensory evoked potentials recorded from DBS leads implanted in the human pedunculopontine tegmental nucleus generated? , 2011, Movement disorders : official journal of the Movement Disorder Society.

[27]  E. González-Pablos,et al.  Adult onset Hallervorden-Spatz disease with psychotic symptoms. , 2011, Actas espanolas de psiquiatria.

[28]  M. Okun,et al.  Nonmotor manifestations of dystonia: A systematic review , 2011, Movement disorders : official journal of the Movement Disorder Society.

[29]  Aart J. Nederveen,et al.  Structural, functional and molecular imaging of the brain in primary focal dystonia—A review , 2011, NeuroImage.

[30]  A. Ormazabal,et al.  Neuropsychiatric symptoms and intelligence quotient in autosomal dominant Segawa disease , 2011, Journal of Neurology.

[31]  Leonardo Franklin Fontenelle,et al.  Psychiatric disorders in primary focal dystonia and in Parkinson’s disease , 2011, Neuropsychiatric disease and treatment.

[32]  L. Forsgren,et al.  A high-penetrance form of late-onset torsion dystonia maps to a novel locus (DYT21) on chromosome 2q14.3-q21.3 , 2011, neurogenetics.

[33]  A. Gregory,et al.  Genetics of Neurodegeneration with Brain Iron Accumulation , 2011, Current neurology and neuroscience reports.

[34]  A. Albanese,et al.  EFNS guidelines on diagnosis and treatment of primary dystonias , 2011, European journal of neurology.

[35]  G. M. Contessa,et al.  A Transverse and Longitudinal MR Imaging Voxel-Based Morphometry Study in Patients with Primary Cervical Dystonia , 2010, American Journal of Neuroradiology.

[36]  S. Hollon,et al.  A review of empirically supported psychological therapies for mood disorders in adults , 2010, Depression and anxiety.

[37]  P. Krack,et al.  Deep brain stimulation: from neurology to psychiatry? , 2010, Trends in Neurosciences.

[38]  J. Hardy,et al.  Indian‐subcontinent NBIA: Unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms , 2010, Movement disorders : official journal of the Movement Disorder Society.

[39]  D. Eidelberg,et al.  Functional imaging in hereditary dystonia , 2010, European journal of neurology.

[40]  F. Asmus,et al.  Dystonia‐plus syndromes , 2010, European journal of neurology.

[41]  A. Berardelli,et al.  Psychiatric disorders in adult‐onset focal dystonia: A case‐control study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[42]  Y. Kuroiwa,et al.  Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: Clinical features and 99mTc-ECD brain perfusion SPECT findings , 2010, Journal of the Neurological Sciences.

[43]  C. Ki,et al.  Novel PANK2 gene mutations in Korean patient with pantothenate kinase‐associated neurodegeneration presenting unilateral dystonic tremor , 2010, Movement disorders : official journal of the Movement Disorder Society.

[44]  F. Micheli,et al.  Cognitive disturbances in primary blepharospasm , 2009, Movement disorders : official journal of the Movement Disorder Society.

[45]  Nagagopal Venna,et al.  Case 26-2006 , 2009 .

[46]  M. Vidailhet,et al.  Pathophysiology of dystonia , 2009, Current opinion in neurology.

[47]  Daniel Bullock,et al.  Computational perspectives on forebrain microcircuits implicated in reinforcement learning, action selection, and cognitive control , 2009, Neural Networks.

[48]  E. Foncke,et al.  Is Psychopathology Part of the Phenotypic Spectrum of Myoclonus-dystonia?: A Study of a Large Dutch M-D Family , 2009, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[49]  R. Lencer,et al.  Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[50]  S. Bressman,et al.  Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia , 2009, Nature Genetics.

[51]  E. Bullmore,et al.  Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited , 2008, Neuroscience & Biobehavioral Reviews.

[52]  F. Ruissen,et al.  Myoclonus–dystonia: clinical and genetic evaluation of a large cohort , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[53]  M. Jahanshahi,et al.  Depression in focal, segmental and generalized dystonia , 2008, Journal of Neurology.

[54]  A. Gregory,et al.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation , 2008, Journal of Medical Genetics.

[55]  D. Shohamy,et al.  Integrating Memories in the Human Brain: Hippocampal-Midbrain Encoding of Overlapping Events , 2008, Neuron.

[56]  K P Bhatia,et al.  Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[57]  D. Hernandez,et al.  Characterization of PLA2G6 as a locus for dystonia‐parkinsonism , 2008, Annals of neurology.

[58]  M. Hallett,et al.  The pathophysiological basis of dystonias , 2008, Nature Reviews Neuroscience.

[59]  C. Colosimo,et al.  Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm , 2008, European journal of neurology.

[60]  V. Fung,et al.  Myoclonus‐dystonia: significance of large SGCE deletions , 2008, Human mutation.

[61]  P. Bugalho,et al.  Set‐shifting and behavioral dysfunction in primary focal dystonia , 2008, Movement disorders : official journal of the Movement Disorder Society.

[62]  S. Ochudło,et al.  Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm. , 2007, Parkinsonism & related disorders.

[63]  C. Tomaz,et al.  Sustained attention in cranial dystonia patients treated with botulinum toxin , 2007, Acta neurologica Scandinavica.

[64]  H. Gündel,et al.  Psychiatric comorbidity in patients with spasmodic dysphonia: a controlled study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[65]  A. Misbahuddin,et al.  Myoclonus–dystonia syndrome with severe depression is caused by an exon‐skipping mutation in the ε‐sarcoglycan gene , 2007, Movement disorders : official journal of the Movement Disorder Society.

[66]  E. Nagata,et al.  Dopa‐responsive dystonia (Segawa disease)‐like disease accompanied by mental retardation: A case report , 2007, Movement disorders : official journal of the Movement Disorder Society.

[67]  Peter J. Hogarth,et al.  Intellectual and adaptive behaviour functioning in pantothenate kinase-associated neurodegeneration. , 2007, Journal of intellectual disability research : JIDR.

[68]  C. Barbui,et al.  Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD). , 2007, The Cochrane database of systematic reviews.

[69]  S. Bressman,et al.  Obsessive‐compulsive disorder is not a clinical manifestation of the DYT1 dystonia gene , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[70]  Alexander Münchau,et al.  The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. , 2007, Brain : a journal of neurology.

[71]  S. Bressman,et al.  Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers , 2007, Neurology.

[72]  Nir Giladi,et al.  Neuropsychological profile of DYT1 dystonia , 2006, Movement disorders : official journal of the Movement Disorder Society.

[73]  P. Grant,et al.  Case records of the Massachusetts General Hospital. Case 26-2006. A 19-year-old woman with difficulty walking. , 2006, The New England journal of medicine.

[74]  J. Burgunder,et al.  DYT1 mutations amongst adult primary dystonia patients in Singapore with review of literature comparing East and West , 2006, Journal of the Neurological Sciences.

[75]  E. Nestler,et al.  The Mesolimbic Dopamine Reward Circuit in Depression , 2006, Biological Psychiatry.

[76]  K. Dujardin,et al.  Preservation of cognitive function in dystonia treated by pallidal stimulation , 2006, Neurology.

[77]  R. Baldessarini,et al.  Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics? , 2006, Movement disorders : official journal of the Movement Disorder Society.

[78]  J. Steyaert,et al.  Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[79]  H. Teive,et al.  Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm. , 2005, Arquivos de neuro-psiquiatria.

[80]  C. Ploner,et al.  Egocentric and allocentric spatial memory in idiopathic cervical dystonia , 2005, Neurology.

[81]  M. T. Pellecchia,et al.  The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration , 2005, Neurology.

[82]  A. Albanese,et al.  Clinical and neuropsychological correlates in two brothers with pantothenate kinase–associated neurodegeneration , 2005, Movement disorders : official journal of the Movement Disorder Society.

[83]  N. Risch,et al.  Increased risk for recurrent major depression in DYT1 dystonia mutation carriers , 2004, Neurology.

[84]  William B Dobyns,et al.  Mutations in the Na+/K+-ATPase α3 Gene ATP1A3 Are Associated with Rapid-Onset Dystonia Parkinsonism , 2004, Neuron.

[85]  Jasper A. J. Smits,et al.  Cognitive-behavioral therapy for the treatment of anxiety disorders. , 2004, The Journal of clinical psychiatry.

[86]  J. Jankovic,et al.  Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden‐Spatz syndrome) and pantothenate kinase‐associated neurodegeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.

[87]  M. Jahanshahi,et al.  Cognitive executive function in dystonia , 2003, Movement disorders : official journal of the Movement Disorder Society.

[88]  G. Deda,et al.  Psychotic disorder in a case with Hallervorden–Spatz disease , 2003, Acta psychiatrica Scandinavica.

[89]  J. Molinuevo,et al.  Pure akinesia: An unusual phenotype of Hallervorden‐Spatz syndrome , 2003, Movement disorders : official journal of the Movement Disorder Society.

[90]  H. Gündel,et al.  HIGH PSYCHIATRIC COMORBIDITY IN SPASMODIC TORTICOLLIS: A CONTROLLED STUDY , 2003, The Journal of nervous and mental disease.

[91]  D. Campion,et al.  Severe myoclonus‐dystonia syndrome associated with a novel epsilon‐sarcoglycan gene truncating mutation , 2003, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

[92]  T. Aziz,et al.  Executive cognitive deficits in primary dystonia , 2003, Movement disorders : official journal of the Movement Disorder Society.

[93]  B. Levinson,et al.  Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. , 2003, The New England journal of medicine.

[94]  N. Risch,et al.  Diagnostic criteria for dystonia in DYT1 families , 2002, Neurology.

[95]  G. Cossu,et al.  Hallervorden Spatz syndrome (pantothenate kinase associated neurodegeneration) in two Sardinian brother with homozygous mutation in PANK 2 gene , 2002, Journal of Neurology.

[96]  M. Brin,et al.  Phenotypic features of myoclonus-dystonia in three kindreds , 2002, Neurology.

[97]  M. Brin,et al.  Clinical findings of a myoclonus-dystonia family with two distinct mutations , 2002, Neurology.

[98]  G. Deuschl,et al.  Myoclonus–dystonia syndrome: ε‐sarcoglycan mutations and phenotype , 2002, Annals of neurology.

[99]  J. Reimer,et al.  Quetiapine improves involuntary movements after cerebellar stroke , 2002, Journal of Neurology.

[100]  G. Comi,et al.  Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study , 2002, Biological Psychiatry.

[101]  W. Poewe,et al.  The impact of blepharospasm and cervical dystonia on health-related quality of life and depression , 2002, Journal of Neurology.

[102]  D. Dobie.  Depression, dementia, and pseudodementia. , 2002, Seminars in clinical neuropsychiatry.

[103]  Y. Ben-Shlomo,et al.  What are the determinants of quality of life in people with cervical dystonia? , 2002, Journal of neurology, neurosurgery, and psychiatry.

[104]  J. Yelnik.  Functional anatomy of the basal ganglia , 2002, Movement disorders : official journal of the Movement Disorder Society.

[105]  N. Risch,et al.  Myoclonus-dystonia , 2010, Journal of Pediatric Neurology.

[106]  H. Gündel,et al.  Social phobia in spasmodic torticollis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[107]  T. Meitinger,et al.  Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome , 2001, Nature Genetics.

[108]  T Murai,et al.  Obsessive-compulsive characteristics in patients with writer's cramp , 2001, Journal of neurology, neurosurgery, and psychiatry.

[109]  N. Blau,et al.  Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. , 2001, American journal of human genetics.

[110]  Shawn K. Westaway,et al.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome , 2001, Nature Genetics.

[111]  M. Brownstein,et al.  Neurologic and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene. , 2001, Archives of neurology.

[112]  N W Wood,et al.  DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13–36.32 in an Italian family with cranial‐cervical or upper limb onset , 2001, Annals of neurology.

[113]  M. Brin,et al.  A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. , 2000, American journal of human genetics.

[114]  O. Hardiman,et al.  Rapid-onset dystonia-parkinsonism , 2000, Neurology.

[115]  M. Segawa.  Hereditary progressive dystonia with marked diurnal fluctuation , 2000, Brain and Development.

[116]  R. Cabeza,et al.  Neural bases of learning and memory: functional neuroimaging evidence , 2000, Current opinion in neurology.

[117]  D. Jennings,et al.  Localization of a gene for myoclonus‐dystonia to chromosome 7q21‐q31 , 1999, Annals of neurology.

[118]  C. Marsden,et al.  SSRI‐induced reversal of levodopa benefit in two patients with dopa‐responsive dystonia , 1999, Movement disorders : official journal of the Movement Disorder Society.

[119]  F. Gabreëls,et al.  Biochemical hallmarks of tyrosine hydroxylase deficiency. , 1998, Clinical chemistry.

[120]  M. Nitschke,et al.  Dopa responsive dystonia with Turner’s syndrome: clinical, genetic, and neuropsychological studies in a family with a new mutation in the GTP-cyclohydrolase I gene , 1998, Journal of neurology, neurosurgery, and psychiatry.

[121]  L. Lynd,et al.  Selective Serotonin-Reuptake Inhibitor–Induced Movement Disorders , 1998, The Annals of pharmacotherapy.

[122]  T. Wenzel,et al.  Psychiatric comorbidity in patients with spasmodic torticollis. , 1998, Journal of psychosomatic research.

[123]  D. Dressler,et al.  Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm. , 1998, The American journal of psychiatry.

[124]  M. Brin,et al.  Idiopathic torsion dystonia linked to chromosome 8 in two mennonite families , 1997, Annals of neurology.

[125]  K. Nakashima,et al.  Hereditary non-progressive torsion dystonia with intellectual disturbance. , 1995, Internal medicine.

[126]  A. Parent,et al.  Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop , 1995, Brain Research Reviews.

[127]  S. Tsuji,et al.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene , 1994, Nature Genetics.

[128]  B. Leplow,et al.  Visuospatial Functions in Patients with Spasmodic Torticollis , 1994, Perceptual and motor skills.

[129]  E. Rüther,et al.  Clozapine treatment of spasmodic torticollis , 1994, Neurology.

[130]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[131]  C. Marsden,et al.  Psychological functioning before and after treatment of torticollis with botulinum toxin. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[132]  J. Saint-Cyr,et al.  Cognitive processes in idiopathic dystonia treated with high-dose anticholinergic therapy: implications for treatment strategies. , 1991, Clinical neuropharmacology.

[133]  N. Risch,et al.  Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32–34 , 1990, Annals of neurology.

[134]  P. Lavie,et al.  Fluctuating dystonia responsive to levodopa. , 1987, Archives of disease in childhood.

[135]  J. Jankovic,et al.  Hemidystonia: a report of 22 patients and a review of the literature. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[136]  Ellis Bindman,et al.  Writer's Cramp—A Rational Approach to Treatment? , 1977, British Journal of Psychiatry.

[137]  R. Eldridge.  The torsion dystonias , 1970, Neurology.

[138]  J. Brody,et al.  Increased intelligence in recessively inherited torsion dystonia (dystonia musculorum deformans). , 1970, Neurology.

[139]  G. Kirov,et al.  SGCE mutations cause psychiatric disorders: clinical and genetic characterization. , 2013, Brain : a journal of neurology.

[140]  M. Mula,et al.  Obsessive-compulsive-spectrum symptoms in patients with focal dystonia, hemifacial spasm, and healthy subjects. , 2012, The Journal of neuropsychiatry and clinical neurosciences.

[141]  N. Nardocci.  Myoclonus-dystonia syndrome. , 2011, Handbook of clinical neurology.

[142]  Lars Nyberg,et al.  Training of the executive component of working memory: subcortical areas mediate transfer effects. , 2009, Restorative neurology and neuroscience.

[143]  B. Leplow,et al.  Impairment of visuospatial function in idiopathic spasmodic torticollis , 2004, Journal of Neurology.

[144]  N. Nishiyama,et al.  Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease) , 2003, Annals of neurology.

[145]  T. Wenzel,et al.  Relation between depression and anxiety in dystonic patients: implications for clinical management , 2002, Depression and anxiety.

[146]  T. Gasser.  Inherited myoclonus-dystonia syndrome. , 1998, Advances in neurology.

[147]  E. Lauterbach,et al.  Clinical, motor, and biological correlates of depressive disorders after focal subcortical lesions. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[148]  R. Scully,et al.  Case records of the Massachusetts General Hospital. , 1990 .

[149]  L. Forsgren,et al.  Alcohol‐responsive myoclonic dystonia in a large family: Dominant inheritance and phenotypic variation , 1990, Movement disorders : official journal of the Movement Disorder Society.

[150]  J. Obeso,et al.  Clinicopathological correlation in symptomatic dystonia. , 1988, Advances in neurology.

[151]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[152]  M. Riklan,et al.  Psychological studies in dystonia musculorum deformans. , 1976, Advances in neurology.

[153]  C. Marsden,et al.  Idiopathic torsion dystonia (dystonia musculorum deformans). A review of forty-two patients. , 1974, Brain : a journal of neurology.

[154]  E. Dooling,et al.  Hallervorden-Spatz syndrome. , 1974, Archives of neurology.